Could a puff of inhaled epinephrine stop severe allergic reactions?
NCT ID NCT07038746
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests if inhaled epinephrine can quickly ease systemic allergic reactions that happen during allergy testing or treatment. About 100 people aged 12 and older with known allergies will take part. The goal is to see how fast symptoms improve, aiming for a safer and easier way to manage allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kokua Pharma Inc.
RECRUITINGRichmond, British Columbia, V7C 5L9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin test skip for Kids' antibiotic allergies shows promise
- AI tool aims to cut allergy misdiagnosis in primary care
- Can allergy drugs help kids tolerate peanut and more?
- Salmon plant study aims to stop asthma before it starts
- VR training could match High-Tech mannequins for emergency drills
- Milk allergy treatment shows promise in Long-Term quality of life study